Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 4 B lane 6
Lichtig H et al. (2020)
|
Xla Wt + asxl3 MO + animal cap amputation
NF16 (RT-PCR)
|
|
|
|
Fig. 7 B col 1
Jalvy S et al. (2019)
|
Xla Wt + igf1 + animal explant
NF 18 (RT-PCR)
|
|
|
|
Fig. 5 B row 1 col 2
Jalvy S et al. (2019)
|
Xla Wt + lif
NF 18- NF 21 (in situ hybridization)
|
|
|
|
Fig. 5 C
Jalvy S et al. (2019)
|
Xla Wt + lif
NF 22 (RT-PCR)
|
|
|
|
Fig. 3 i
Harata A et al. (2019)
|
Xla Wt + p2ry4 TALEN
NF14 (in situ hybridization)
|
|
|
|
Fig.8.b,d
Pai VP et al. (2018)
|
Xla Wt + Nicotine
NF25 (in situ hybridization)
|
|
|
|
fig.6.f
Ding Y et al. (2017)
|
Xla Wt + pkdcc.1
NF16 (morphology)
|
|
|
|
fig.8
Popov IK et al. (2017)
|
Xla Wt + pkdcc.1 MO
NF17 (in situ hybridization)
|
|
|
|
fig.1.m
Eroshkin FM et al. (2016)
|
Xla Wt + nog
NF15 (in situ hybridization)
|
|
|
|
fig.S5.e
Eroshkin FM et al. (2016)
|
Xla Wt + nog4
NF15 (in situ hybridization)
|
|
|